The Pharma Lab Show: Welcome to The Pharma Lab Show

     

    It’s hard to imagine how new drugs could be developed without appropriate analytical support. This podcast aims to explore the role of analytical within the drug product development lifecycle.

    Rita Richa Producer at Sweet Fish Media, talks with Simon Bates the host of the show and VP of Science and Technology at Rigaku Americas Corporation, and Chris Carolan, Director of Marketing at Rigaku Americas Holding, about what to expect on The Pharma Lab Show.

    What we talked about:

    • Understanding the analytical needs of customers
    • Providing a platform for scientists and business leaders to discuss pharmaceutical development
    • Other topics that will be touched upon during the show

    Key takeaways from this episode

    • “We think this is a great channel that's been underutilized for pharma, and we hope that the knowledge sharing that comes from it can help support the industry.” — Chris Carolan
    • ”What we're trying to achieve is to give a behind-the-scenes perspective on the challenges that have to be overcome to bring new pharmaceuticals to market.” — Simon Bates

    Have an idea for an episode topic or guest? Contact Simon Bates or Chris Carolan on LinkedIn.

    Check out the Rigaku Pharmaceutical Technologies Showcase for more information on Rigaku's commitment to the pharmaceutical industry
    For more insights into the pharmaceutical industry, subscribe to the show on Apple Podcasts, Spotify, or wherever podcasts are found.

    Simon Bates, Ph. D.
    Simon Bates serves customers as the VP of Science and Technology with Rigaku Americas. Simon Bates received his PhD in Applied Physics from the University of Hull, utilizing Neutron diffraction to study the magnetic properties of rare earth materials. The neutron diffraction work was performed at the Institute Laue Langevin in Grenoble. For his postdoctoral work in the Dept. of Physics at the University of Edinburgh, Simon helped design and build high-resolution triple axis X-ray diffraction systems for the study of solid-state phase transformations. Simon continued his work on high resolution X-ray diffraction systems at both Philips NV and Bede Scientific where he was focused on the development of X-ray diffraction and X-ray reflectivity methods for the measurement and modeling of advanced materials. Before moving to Rigaku, Simon spent the last 15 years working in contract research organizations (SSCI and Triclinic Labs) studying solid state pharmaceutical materials. In particular, he was directly involved in the development of advanced characterization methods for formulated pharmaceutical products based on the analysis of structure (crystalline, non-crystalline, meso-phase, polymorph, salt, co-crystal..), microstructure (texture, strain, crystal size, habit..) and their functional relationships in the solid state. Simon also holds an appointment as an Adjunct Professor at LIU in the Division of Pharmaceutical Sciences where he helps teach a graduate course on solid state materials analysis.